Major depressive disorder affects almost 40% more people in the 7MM than previously estimated

A new hope for slowing disability in MS

ChariotMS will be the first multiple sclerosis (MS) clinical trial to include people who can’t...

Increasing use of digital therapeutics in Germany since reimbursement pathway announced

Study finds Pfizer, BioNTech’s vaccine could prevent UK variant Covid-19

Pfizer and BioNTech have announced results from an in vitro study.

Tonix Pharmaceuticals strikes licensing deal to expand use of intranasal drug for metabolic disorders

FDA accepts regulatory submission for Pfizer and OPKO Biologic’s long-acting growth hormone Somatrogon

The UK Records the highest-ever number of Covid-19 cases, despite national lockdown and vaccine

Forxiga’s priority review and breakthrough designation highlight potential to differentiate in CKD space

Phesi and Sensyne to collaborate on synthetic control arms for clinical trials

Synthetic control arms could transform clinical development as they allow companies to overcome in the...

Myovant Sciences and Pfizer collaboration boosts relugolix potential in female health and intensifies competition